Conference Agenda

14th IMARS conference (IMARS-14)
Doha 2021 – Protein glycation in food, health and disease.

20th September 2021. Day 1.

}

16:00

Opening Ceremony

Reading from the Qur’an

}

16:05

Welcome and opening remarks by President of IMARS, Prof Paul J Thornalley (QBRI/HBKU) and Chair IMARS-14 Organizing Committee, Prof Naila Rabbani (Qatar University)
}

16:20

Welcome by Representative from Qatar National Research Fund (QNRF)
}

16:30

Prof Paul J Thornalley (QBRI/HBKU) Doha Glycation Declaration 2021 – Grand challenges in glycation research invitation for input

Session 1: Breakthrough research: The unfolded protein response

}

16-45

Dynamics of function and regulation of the endoplasmic reticulum

Keynote Speaker:
Prof Kazutoshi Mori, Lasker laureate
(Kyoto University, Japan)

Session 2: Diabetes and diabetic complications

}

17-30

Qatar Diabetes Prevention Program (QDPP) – use of A1C in diabetes prevention and control

Prof Abdul-Badi Abou-Samra
(Metabolic Research Institute, Hamad Medical Corp, Qatar)

}

18-00

Transactivation of the Receptor for Advanced Glycation Endproducts mediating proinflammatory signaling in diabetes

Prof Mark Cooper
(Monash University, Australia)

}

18-30

Challenging the Dogma in Diabetic Neuropathy

Prof Rayaz Malik
(Weill-Cornell Medical College, Qatar)

}

19-00

RAGE/DIAPH1: Molecular Mechanisms and Therapeutic Strategies in Obesity and Diabetic Complications

Prof Ann Marie Schmidt
(New York University, USA)

}

19-30

Targeting the gut to reduce AGE-mediated damage in diabetes

Associate Prof Melinda Coughlan (Monash University, Australia)

Day 1 – Close

21st September 2021. Day 2.

}

15-00

Pre-session on-line poster discussion session 1 (Posters 1 – 22)

Session 3: Glycation in food: innovation for a healthy diet

}

16-00

Glycation and development of healthier foods

Prof Vincenzo Fogliano (University of Wageningen, The Netherlands)

}

16-30

Manuka honey and its unique glycation chemistry

Prof Thomas Henle (Technical University of Dresden, Germany)

}

17-00

Does the quote “Sola dosis facit venenum” apply to the physiological effects of glycation adducts?

Prof Fred Tessier
(University of Lille, France)

Short talks

}

17-30

Immunogenicity and allergenicity of glycated cows’ milk proteins

Dr Gosia Teodorowicz
(University of Wageningen, The Netherlands)

}

17-40

Structure of melanoidins formed in the Maillard reaction of methylglyoxal with L-alanine or L-lysine

Dr Clemens Kanzler
(Technische Universität Berlin, Germany)

}

17-50

Fluidized bed roasting drives Maillard reactions toward A more aromatic cocoa

Ruth Fabiola Peña-Correa
(University of Wageningen, The Netherlands)

Session 4: Dicarbonyl stress in obesity and diabetes (with EASD Reactive Metabolites Study Group)

}

18-00

Methylglyoxal stress in obesity and (risk of) type 2 diabetes

Prof Casper G. Schalkwijk (Maastricht University,
The Netherlands)

}

18-30

Dicarbonyl stress in insulin resistance and effect of exercise intervention

Prof Jacob Haus
(University of Michigan, USA)

}

19-00

Dicarbonyl stress in diabetic vascular disease

Prof Bernd Stratmann
(Ruhr-University Bochum, Germany)

Short talks

}

19-30

Higher habitual intake of dietary dicarbonyls is associated with higher concentrations of corresponding plasma dicarbonyls and with skin autofluorescence: the Maastricht Study

Dr Kim Maasen
(Maastricht University, The Netherlands)

}

19-40

Dynamics of hexokinase-2 linked glycolytic overload driving dicarbonyl stress and endothelial cell dysfunction in high glucose concentration in vitro

Prof Naila Rabbani
(Qatar University, Qatar)

}

19-50

Pyridoxamine reduces glycation and markers of endothelial function in a placebo-controlled intervention trial with abdominally obese individuals

Dr Mathias Van den Eynde
(Maastricht University, The Netherlands)

}

20-00 - 20-30

Virtual Trade Exhibition (Exhibitors available on-line for inquiries and discussion)

Day 2 – Close

22nd September 2021. Day 3.

}

15-00

Pre-session on-line poster discussion session 2 (Posters 23 – 44)

Session 5: Glycation in through the life course – from maternal bonding kidney disease and aging

}

16-00

RAGE and maternal bonding – an unexpected mechanistic relationship

Prof Yasuhiko Yamamoto
(Kanazawa University, Japan)

}

16-30

Ascorbic acid as a glycating agent in the aging lens

Prof Vincent Monnier (Case Western Reserve University, USA)

}

17-00

Glyoxalase 1 activity declines with age in many tissues

Prof Allen Taylor
(Tufts University, USA)

Short talks

}

17-30

Short term intraperitoneal administration of mammalian cell derived human soluble receptor for advanced glycation end products (sRAGE) prevents type 1 diabetes onset in mice

Selena Le Bagge
(University of Queensland, Australia)

}

17-40

High hydrostatic pressure processing of human milk avoids the formation of Maillard reaction products and preserves oligosaccharides

Dr Michael Howsam
(University of Lille, France)

}

17-50

Effect of a 4-week diet low and high in AGEs on insulin sensitivity and secretion, vascular function, and markers of low-grade inflammation and endothelial dysfunction of abdominally obese individuals – preliminary results from the deAGEing trial

Armand Linkens
(Maastricht University, The Netherlands)

Session 6: Glycation in plants – physiology, function and food security

}

18-00

Production mechanism of methylglyoxal and its reactivity with oxygen to produce reactive oxygen species in illuminated chloroplasts of plant leaves

Prof Chikahiro Miyake (Kobe University, Japan)

}

18-30

Glycation of plant proteins – a step forward to understanding the biological role

Prof Andrej Frolov
(St. Petersburg State University, Russia & Leibnitz Institute of Plant Biochemistry, Halle, Germany)

}

19-00

Glyoxalases: the antidote for methylglyoxal and plant stress

Prof Sneh L. Singla‐Pareek
(International Centre for Genetic Engineering and Biotechnology, India)

Short talks

}

19-30

Drought-related changes in pea root nodule metabolome

Dr Alena Soboleva
(St. Petersburg State University, Russia & Leibnitz Institute of Plant Biochemistry, Halle, Germany

}

19-40

Evaluation of MG antiviral activity against SARS-CoV-2

Mrs Israa Elbashir
(Qatar University, Qatar)

}

19-50

Anti-inflammatory activity of glyoxalase-1 inducer, trans-resveratrol and hesperetin, in human small airway epithelial cell primary cultures support application for prevention of COVID-19.

Prof Paul J Thornalley
(QBRI/HBKU, Qatar)

}

20-00 - 20-30

Virtual Trade Exhibition (Exhibitors available on-line for inquiries and discussion)

Day 3 – Close

23rd September 2021. Day 4.

}

15-00

Pre-session on-line poster discussion session 3 (Posters 45 – 67)

Session 7: Glycation analytics and chemistry

}

16-00

Detection of reactive carbonyl intermediates of glycation

Prof Monika Pischetsrieder (University of Erlangen-Nuremberg, Germany)

}

16-30

Measurement of AGEs: LC-MS/MS, immunoassay and finger skin autofluorescence

Prof Ryoji Nagai
(Tokai University, Japan)

}

17-00

Mechanochemistry: Maillard Reaction “Through the Looking Glass”

Prof Varoujan Yaylayan (McGill University, Canada)

Short talks

}

17-30

Update to the N6-carboxymethyl lysine story

Prof Marcus Glomb
(Martin-Luther University of Halle, Germany)

}

17-40

Enzymatic decarboxylation of Nε-carboxymethyl-lysine by ornithine decarboxylases reveals underground metabolism as a route for in vivo processing of glycated amino acids

Prof Michael Hellwig
(Technical University Braunschweig & Technical University Desden, Germany)

}

17-50

Polyphenols as trapping agents of reactive carbonyl species: new strategy to reduce harmful compounds in e-cigarette emissions

Dr Alberto Fiore
(University of Abertay, United Kingdom)

Session 8: Glycation in kidney disease, cancer and mental health

}

18-00

Organelle stress and metabolic derangement in kidney disease

Prof Reiko Inagi (University of Tokyo, Japan)

}

18-30

Methylglyoxal metabolism is a targetable liability of glycolytic metabolism in cancer

Prof Matthew Vander Heiden (MIT, USA)

}

19-00

Glycation and mental health – anxiety, depression and schizophrenia

Prof Makoto Arai (University of Tokyo, Japan)

Short talks

}

19-30

Multiple Outcome Studies Confirm Predictive Value of AGEs for Diabetic Kidney Disease

Prof Paul J Beisswenger
(Dartmouth University, USA)

}

19-40

The spliceosome is a target for glycation in methylglyoxal-induced apoptosis and is shielded by glyoxalase 1 in multidrug resistance-linked cancer chemotherapy

Dr Muhanad Alhujaily
(Bisha University, Kingdom of Saudi Arabia)

}

19-50

Methylglyoxal targets proteins involved in mitotic fidelity

Leigh Donnellan
(University of South Australia, Australia)

}

20-00 - 20-30

Virtual Trade Exhibition (Exhibitors available on-line for inquiries and discussion)

Day 4 – Close

24th September 2021. Day 5.

Session 9: Imaging, diagnostic algorithms and therapeutics

}

16-00

Design and synthesis of near-infrared fluorescent probe targeting tumour metabolite methylglyoxal for visualization study

Prof Chunyong Ding
(Shanghai Jiaotong University, China)

}

16-30

Glycation and machine learning – diagnostic algorithms for diabetes, arthritis and autism

Prof Naila Rabbani
(Qatar University, Qatar)

}

17-00

Glycation based therapeutics: Glo1 inducers and Glo1 inhibitors. COVID-19 repurposing

Prof Paul J Thornalley
(QBRI/HBKU, Qatar)

Session 10 : Methods and models in glycation research – Qatar glycation collaboration

}

17-30

Measurement of glyoxalase activities

Dr Sowndramalingam Sankaralingam
(Qatar University, Qatar)

}

17-45

Genetics of glycation – glycated hemoglobin, GLO1 single nucleotide polymorphisms and copy number variation

Maryam Al-Motawa
(QBRI/HBKU, Qatar)

}

18-00

Assay of glyoxalase metabolites: methylglyoxal, S-D-lactoylglutathione and D-lactate

Prof Paul J Thornalley (QBRI/HBKU, Qatar)

}

18-15

Quantitation of glycation adducts by stable isotopic dilution analysis LC-MS/MS

Prof Naila Rabbani
(Qatar University, Qatar)

}

18-30

Proteomics of glycation

Dr Patrick Wijten
(QBRI/HBKU, Qatar)

}

18-45

Application of functional genomics in studies of dicarbonyl stress

Dr Mingzhan Xue
(QBRI/HBKU, Qatar)

}

19-00

Mathematical modelling of glycation

Dr Alberto da la Fuente (QBRI/HBKU, Qatar)

}

19-15

Glycation in drug repurposing for COVID-19

Dr Hebah Al Khatib
(Qatar University, Qatar)

}

19-30

Inducible pluripotent stem cells (iPSC) application in diabetes and glycation research

Dr Essam Abdelalim
(QBRI/HBKU, Qatar)

}

19-45

• Grand challenges in glycation research – Doha Glycation Declaration 2021
• IMARS Society – change of President

Prof Paul J Thornalley
(IMARS President, QBRI/HBKU, Qatar)

Day 5 – Conference Close